| 2021-08-17 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,407 0.002% | $17.12 | $24,085 | +30.66% | |
| 2021-07-28 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,250 0.002% | $13.81 | $17,263 | +79.91% | |
| 2021-05-12 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 375 0.0006% | $19.46 | $7,298 | +30.12% | |
| 2021-05-11 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 375 0.0006% | $19.14 | $7,178 | +27.23% | |
| 2021-02-08 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,125 0.002% | $31.58 | $35,528 | -19.42% | |
| 2021-02-05 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,125 0.002% | $31.41 | $35,336 | -21.33% | |
| 2021-02-03 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,813 0.0031% | $28.91 | $52,414 | -17.7% | |
| 2021-02-02 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,813 0.0034% | $30.75 | $55,750 | -13.09% | |
| 2020-09-23 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 750 0.0015% | $18.48 | $13,860 | +31.7% | |
| 2020-09-22 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 750 0.0015% | $18.59 | $13,943 | +23.98% | |
| 2020-07-28 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 870 0.0017% | $20.49 | $17,826 | +6.72% | |
| 2020-05-12 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 527 0.0012% | $16.98 | $8,951 | +30.78% | |
| 2020-03-05 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,790 0.004% | $15.36 | $27,487 | +26.69% | |
| 2019-07-31 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,250 0.003% | $20.07 | $25,088 | -23.55% | |
| 2019-07-30 | Sale | Travere Therapeutics, Inc. TVTX | Chief Medical Officer | 1,250 0.0029% | $19.82 | $24,775 | -24.99% |